{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:39:42Z","timestamp":1790293182301,"version":"4.1.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.rdc.2016.12.009","type":"journal-article","created":{"date-parts":[[2017,3,14]],"date-time":"2017-03-14T02:01:52Z","timestamp":1489456912000},"page":"215-226","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":91,"title":["Systemic Lupus Erythematosus and Pregnancy"],"prefix":"10.1016","volume":"43","author":[{"given":"Aisha","family":"Lateef","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Petri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.rdc.2016.12.009_bib1","first-page":"1709","article-title":"Decrease in pregnancy loss rates in patients with systemic lupus erythematosus over a 40-year period","volume":"32","author":"Clark","year":"2005","journal-title":"J\u00a0Rheumatol"},{"issue":"2","key":"10.1016\/j.rdc.2016.12.009_bib2","doi-asserted-by":"crossref","first-page":"127.e1-6","DOI":"10.1016\/j.ajog.2008.03.012","article-title":"A\u00a0national study of the complications of lupus in pregnancy","volume":"199","author":"Clowse","year":"2008","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.rdc.2016.12.009_bib3","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/art.21663","article-title":"Obstetric hospitalizations in the United States for women with systemic lupus erythematosus and rheumatoid arthritis","volume":"54","author":"Chakravarty","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.rdc.2016.12.009_bib4","first-page":"967","article-title":"Healthcare costs of pregnancy in systemic lupus erythematosus: retrospective observational analysis from a US health claims database","volume":"18","author":"Petri","year":"2015","journal-title":"J\u00a0Med Econ"},{"issue":"12","key":"10.1016\/j.rdc.2016.12.009_bib5","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nrrheum.2012.133","article-title":"Management of pregnancy in systemic lupus erythematosus","volume":"8","author":"Lateef","year":"2012","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"10.1016\/j.rdc.2016.12.009_bib6","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/rheumatology\/41.6.643","article-title":"Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus: a prospective study of 103 pregnancies","volume":"41","author":"Cortes-Hernandez","year":"2002","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.rdc.2016.12.009_bib7","doi-asserted-by":"crossref","first-page":"754","DOI":"10.3899\/jrheum.090872","article-title":"The effect of lupus nephritis on pregnancy outcome and fetal and maternal complications","volume":"37","author":"Gladman","year":"2010","journal-title":"J\u00a0Rheumatol"},{"issue":"2","key":"10.1016\/j.rdc.2016.12.009_bib8","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/ndt\/gfn348","article-title":"Pregnancy in women with pre-existing lupus nephritis: predictors of fetal and maternal outcome","volume":"24","author":"Imbasciati","year":"2009","journal-title":"Nephrol Dial Transplant"},{"issue":"2\u20133","key":"10.1016\/j.rdc.2016.12.009_bib9","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s12026-014-8577-1","article-title":"Risk factors of systemic lupus erythematosus flares during pregnancy","volume":"60","author":"Jara","year":"2014","journal-title":"Immunol Res"},{"issue":"2","key":"10.1016\/j.rdc.2016.12.009_bib10","doi-asserted-by":"crossref","first-page":"131","DOI":"10.7326\/L15-0500","article-title":"Predictors of pregnancy outcomes in patients with lupus","volume":"164","author":"Buyon","year":"2016","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.rdc.2016.12.009_bib11","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.rdc.2007.01.003","article-title":"The Hopkins Lupus Pregnancy Center: ten key issues in management","volume":"33","author":"Petri","year":"2007","journal-title":"Rheum Dis Clin North Am"},{"issue":"6","key":"10.1016\/j.rdc.2016.12.009_bib12","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.3899\/jrheum.100746","article-title":"The clinical utility of measuring complement and anti-dsDNA antibodies during pregnancy in patients with systemic lupus erythematosus","volume":"38","author":"Clowse","year":"2011","journal-title":"J\u00a0Rheumatol"},{"issue":"10","key":"10.1016\/j.rdc.2016.12.009_bib13","first-page":"S193","article-title":"Decrease in complement (C3) levels during systemic lupus erythematosus pregnancy is associated with higher rates of pre-eclampsia","volume":"62","author":"Lateef","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.rdc.2016.12.009_bib14","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/ar1957","article-title":"Anti-inflammatory and immunosuppressive drugs and reproduction","volume":"8","author":"Ostensen","year":"2006","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"10.1016\/j.rdc.2016.12.009_bib15","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1136\/annrheumdis-2015-208840","article-title":"The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation","volume":"75","author":"Gotestam Skorpen","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.rdc.2016.12.009_bib16","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1056\/NEJMoa071453","article-title":"Long-term outcomes after repeat doses of antenatal corticosteroids","volume":"357","author":"Wapner","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.rdc.2016.12.009_bib17","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1002\/art.22159","article-title":"Hydroxychloroquine in lupus pregnancy","volume":"54","author":"Clowse","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.rdc.2016.12.009_bib18","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1191\/096120301678646137","article-title":"Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study","volume":"10","author":"Levy","year":"2001","journal-title":"Lupus"},{"issue":"1","key":"10.1016\/j.rdc.2016.12.009_bib19","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1161\/CIRCULATIONAHA.111.089268","article-title":"Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA\/Ro-antibody-associated cardiac manifestations of neonatal lupus","volume":"126","author":"Izmirly","year":"2012","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.rdc.2016.12.009_bib20","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1136\/ard.2009.119263","article-title":"Evaluation of the risk of anti-SSA\/Ro-SSB\/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxychloroquine","volume":"69","author":"Izmirly","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.rdc.2016.12.009_bib21","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/acr.21888","article-title":"In utero azathioprine exposure and increased utilization of special educational services in children born to mothers with systemic lupus erythematosus","volume":"65","author":"Marder","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"7","key":"10.1016\/j.rdc.2016.12.009_bib22","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1002\/art.34419","article-title":"Pregnancy outcome in women exposed to leflunomide before or during pregnancy","volume":"64","author":"Cassina","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.rdc.2016.12.009_bib23","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1002\/art.27358","article-title":"Birth outcomes in women who have taken leflunomide during pregnancy","volume":"62","author":"Chambers","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.rdc.2016.12.009_bib24","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1002\/art.39521","article-title":"Brief report: patterns and secular trends in use of immunomodulatory agents during pregnancy in women with rheumatic conditions","volume":"68","author":"Desai","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"10.1016\/j.rdc.2016.12.009_bib25","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.berh.2013.07.005","article-title":"Managing lupus patients during pregnancy","volume":"27","author":"Lateef","year":"2013","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.rdc.2016.12.009_bib26","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/art.20864","article-title":"The impact of increased lupus activity on obstetric outcomes","volume":"52","author":"Clowse","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"2 Pt 1","key":"10.1016\/j.rdc.2016.12.009_bib27","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/01.AOG.0000194205.95870.86","article-title":"Early risk factors for pregnancy loss in lupus","volume":"107","author":"Clowse","year":"2006","journal-title":"Obstet Gynecol"},{"issue":"7","key":"10.1016\/j.rdc.2016.12.009_bib28","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1002\/art.34402","article-title":"Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies","volume":"64","author":"Lockshin","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.rdc.2016.12.009_bib29","doi-asserted-by":"crossref","first-page":"e000095","DOI":"10.1136\/lupus-2015-000095","article-title":"Lupus anticoagulant, disease activity and low complement in the first trimester are predictive of pregnancy loss","volume":"2","author":"Mankee","year":"2015","journal-title":"Lupus Sci Med"},{"issue":"1","key":"10.1016\/j.rdc.2016.12.009_bib30","doi-asserted-by":"crossref","first-page":"e000131","DOI":"10.1136\/lupus-2015-000131","article-title":"Lupus anticoagulant is the main predictor of adverse pregnancy outcomes in aPL-positive patients: validation of PROMISSE study results","volume":"3","author":"Yelnik","year":"2016","journal-title":"Lupus Sci Med"},{"issue":"10","key":"10.1016\/j.rdc.2016.12.009_bib31","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1002\/acr.22847","article-title":"Racial and ethnic disparities in the pregnancies of women with systemic lupus erythematosus","volume":"68","author":"Clowse","year":"2016","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"7","key":"10.1016\/j.rdc.2016.12.009_bib32","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1177\/0961203310394894","article-title":"Thyroid disease in pregnant women with systemic lupus erythematosus: increased preterm delivery","volume":"20","author":"Stagnaro-Green","year":"2011","journal-title":"Lupus"},{"issue":"12","key":"10.1016\/j.rdc.2016.12.009_bib33","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1002\/art.39320","article-title":"Increased risk of autism spectrum disorders in children born to women with systemic lupus erythematosus: results from a large population-based cohort","volume":"67","author":"Vinet","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"11","key":"10.1016\/j.rdc.2016.12.009_bib34","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1177\/0961203314541691","article-title":"Neurodevelopmental disorders in children born to mothers with systemic lupus erythematosus","volume":"23","author":"Vinet","year":"2014","journal-title":"Lupus"},{"issue":"6","key":"10.1016\/j.rdc.2016.12.009_bib35","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1016\/j.ajog.2005.02.063","article-title":"Factors that predict prematurity and preeclampsia in pregnancies that are complicated by systemic lupus erythematosus","volume":"192","author":"Chakravarty","year":"2005","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.rdc.2016.12.009_bib36","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.bpobgyn.2011.01.006","article-title":"Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy","volume":"25","author":"Hutcheon","year":"2011","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"3","key":"10.1016\/j.rdc.2016.12.009_bib37","doi-asserted-by":"crossref","first-page":"e1001013","DOI":"10.1371\/journal.pmed.1001013","article-title":"Mutations in complement regulatory proteins predispose to preeclampsia: a genetic analysis of the PROMISSE cohort","volume":"8","author":"Salmon","year":"2011","journal-title":"PLoS Med"},{"issue":"1","key":"10.1016\/j.rdc.2016.12.009_bib38","doi-asserted-by":"crossref","first-page":"108.e1-14","DOI":"10.1016\/j.ajog.2015.09.066","article-title":"Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study","volume":"214","author":"Kim","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.rdc.2016.12.009_bib39","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/OGX.0b013e3182227027","article-title":"Evaluation of 7 serum biomarkers and uterine artery Doppler ultrasound for first-trimester prediction of preeclampsia: a systematic review","volume":"66","author":"Kuc","year":"2011","journal-title":"Obstet Gynecol Surv"},{"issue":"7","key":"10.1016\/j.rdc.2016.12.009_bib40","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/j.1471-0528.2012.03311.x","article-title":"Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms-like tyrosine kinase 1 and soluble endoglin in the prediction of pre-eclampsia: a systematic review and meta-analysis","volume":"119","author":"Kleinrouweler","year":"2012","journal-title":"BJOG"},{"issue":"2","key":"10.1016\/j.rdc.2016.12.009_bib41","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/0961203314551812","article-title":"Renal biopsy in the management of lupus nephritis during pregnancy","volume":"24","author":"Chen","year":"2015","journal-title":"Lupus"},{"issue":"3","key":"10.1016\/j.rdc.2016.12.009_bib42","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/acr.20402","article-title":"Contraceptive counseling and use among women with systemic lupus erythematosus: a gap in health care quality?","volume":"63","author":"Yazdany","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"2\u20133","key":"10.1016\/j.rdc.2016.12.009_bib43","doi-asserted-by":"crossref","first-page":"J170","DOI":"10.1016\/j.jaut.2011.11.002","article-title":"Hormone replacement and contraceptive therapy in autoimmune diseases","volume":"38","author":"Lateef","year":"2012","journal-title":"J\u00a0Autoimmun"},{"issue":"11","key":"10.1016\/j.rdc.2016.12.009_bib44","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1177\/0961203315578765","article-title":"Primary prophylaxis to prevent obstetric complications in asymptomatic women with antiphospholipid antibodies: a systematic review","volume":"24","author":"Amengual","year":"2015","journal-title":"Lupus"},{"issue":"4","key":"10.1016\/j.rdc.2016.12.009_bib45","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3899\/jrheum.120576","article-title":"Treatment of 139 pregnancies in antiphospholipid-positive women not fulfilling criteria for antiphospholipid syndrome: a retrospective study","volume":"40","author":"Del Ross","year":"2013","journal-title":"J\u00a0Rheumatol"},{"issue":"2","key":"10.1016\/j.rdc.2016.12.009_bib46","article-title":"Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant","author":"Empson","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.rdc.2016.12.009_bib47","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/rheumatology\/kep373","article-title":"Combination of heparin and aspirin is superior to aspirin alone in enhancing live births in patients with recurrent pregnancy loss and positive anti-phospholipid antibodies: a meta-analysis of randomized controlled trials and meta-regression","volume":"49","author":"Mak","year":"2010","journal-title":"Rheumatology (Oxford)"},{"issue":"25","key":"10.1016\/j.rdc.2016.12.009_bib48","doi-asserted-by":"crossref","first-page":"6948","DOI":"10.1182\/blood-2011-02-339234","article-title":"First-trimester low-dose prednisolone in refractory antiphospholipid antibody-related pregnancy loss","volume":"117","author":"Bramham","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.rdc.2016.12.009_bib49","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0002-9378(00)70500-X","article-title":"A\u00a0multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. The Pregnancy Loss Study Group","volume":"182","author":"Branch","year":"2000","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.rdc.2016.12.009_bib50","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ijgo.2007.05.045","article-title":"Plasmapheresis and pregnancy outcome in patients with antiphospholipid syndrome","volume":"99","author":"El-Haieg","year":"2007","journal-title":"Int J Gynaecol Obstet"},{"issue":"2","key":"10.1016\/j.rdc.2016.12.009_bib51","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.rdc.2007.02.005","article-title":"Neonatal lupus syndromes","volume":"33","author":"Izmirly","year":"2007","journal-title":"Rheum Dis Clin North Am"},{"issue":"5","key":"10.1016\/j.rdc.2016.12.009_bib52","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrrheum.2015.29","article-title":"The clinical spectrum of autoimmune congenital heart block","volume":"11","author":"Brito-Zeron","year":"2015","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"10.1016\/j.rdc.2016.12.009_bib53","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1177\/0961203315624024","article-title":"Autoimmune congenital heart block: complex and unusual situations","volume":"25","author":"Brito-Zeron","year":"2016","journal-title":"Lupus"},{"issue":"3","key":"10.1016\/j.rdc.2016.12.009_bib54","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1365-3083.2010.02434.x","article-title":"Diagnosing foetal atrioventricular heart blocks","volume":"72","author":"Sonesson","year":"2010","journal-title":"Scand J Immunol"},{"issue":"3","key":"10.1016\/j.rdc.2016.12.009_bib55","first-page":"139","article-title":"Cardiac manifestations of neonatal lupus erythematosus: guidelines to management, integrating clues from the bench and bedside","volume":"5","author":"Buyon","year":"2009","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"8","key":"10.1016\/j.rdc.2016.12.009_bib56","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.amjcard.2008.12.027","article-title":"Prospective evaluation of fetuses with autoimmune-associated congenital heart block followed in the PR Interval and Dexamethasone Evaluation (PRIDE) Study","volume":"103","author":"Friedman","year":"2009","journal-title":"Am J Cardiol"},{"issue":"12","key":"10.1016\/j.rdc.2016.12.009_bib57","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.autrev.2015.08.005","article-title":"Description of 214 cases of autoimmune congenital heart block: results of the French neonatal lupus syndrome","volume":"14","author":"Levesque","year":"2015","journal-title":"Autoimmun Rev"},{"issue":"6","key":"10.1016\/j.rdc.2016.12.009_bib58","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1136\/annrheumdis-2015-208311","article-title":"Assessment of fluorinated steroids to avert progression and mortality in anti-SSA\/Ro-associated cardiac injury limited to the fetal conduction system","volume":"75","author":"Izmirly","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.rdc.2016.12.009_bib59","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1161\/01.CIR.0000142046.58632.3A","article-title":"Transplacental fetal treatment improves the outcome of prenatally diagnosed complete atrioventricular block without structural heart disease","volume":"110","author":"Jaeggi","year":"2004","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.rdc.2016.12.009_bib60","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/art.27308","article-title":"Evaluation of fetuses in a study of intravenous immunoglobulin as preventive therapy for congenital heart block: results of a multicenter, prospective, open-label clinical trial","volume":"62","author":"Friedman","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.rdc.2016.12.009_bib61","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/art.27350","article-title":"Failure of intravenous immunoglobulin to prevent congenital heart block: findings of a multicenter, prospective, observational study","volume":"62","author":"Pisoni","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.rdc.2016.12.009_bib62","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/BOR.0000000000000030","article-title":"Systemic lupus erythematosus and pregnancy outcomes: an update and review of the literature","volume":"26","author":"Peart","year":"2014","journal-title":"Curr Opin Rheumatol"},{"issue":"2 Pt 1","key":"10.1016\/j.rdc.2016.12.009_bib63","first-page":"396","article-title":"ACOG practice bulletin no. 125: chronic hypertension in pregnancy","volume":"119","author":"American College of Obstetricians and Gynecologists","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.rdc.2016.12.009_bib64","first-page":"105918","article-title":"A\u00a0comprehensive review of hypertension in pregnancy","volume":"2012","author":"Mustafa","year":"2012","journal-title":"J\u00a0Pregnancy"},{"issue":"23","key":"10.1016\/j.rdc.2016.12.009_bib65","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa055202","article-title":"Major congenital malformations after first-trimester exposure to ACE inhibitors","volume":"354","author":"Cooper","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rdc.2016.12.009_bib66","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3899\/jrheum.120344","article-title":"Safety of pain therapy during pregnancy and lactation in patients with inflammatory arthritis: a systematic literature review","volume":"90","author":"Adams","year":"2012","journal-title":"J\u00a0Rheumatol Suppl"},{"issue":"14","key":"10.1016\/j.rdc.2016.12.009_bib67","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1161\/CIRCULATIONAHA.114.003902","article-title":"Cardiovascular management in pregnancy: antithrombotic agents and antiplatelet agents","volume":"132","author":"Yarrington","year":"2015","journal-title":"Circulation"},{"issue":"27","key":"10.1016\/j.rdc.2016.12.009_bib68","doi-asserted-by":"crossref","first-page":"4562","DOI":"10.2174\/092986712803306466","article-title":"Anticoagulant therapy during pregnancy for maternal and fetal acquired and inherited thrombophilia","volume":"19","author":"Giannubilo","year":"2012","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.rdc.2016.12.009_bib69","doi-asserted-by":"crossref","first-page":"f1169","DOI":"10.1136\/bmj.f1169","article-title":"Association between maternal serum 25-hydroxyvitamin D level and pregnancy and neonatal outcomes: systematic review and meta-analysis of observational studies","volume":"346","author":"Aghajafari","year":"2013","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.rdc.2016.12.009_bib70","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008873.pub2","article-title":"Vitamin D supplementation for women during pregnancy","author":"De-Regil","year":"2012","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X16301120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X16301120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:16:59Z","timestamp":1760181419000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X16301120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":70,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S0889857X16301120"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2016.12.009","relation":{},"ISSN":["0889-857X"],"issn-type":[{"value":"0889-857X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic Lupus Erythematosus and Pregnancy","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2016.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}